SiLaC versus PEPSiT for pediatric pilonidal sinus disease: a monocentric retrospective cohort study (PILO-LASER)
Abstract Purpose Evidence comparing minimally invasive approaches for pediatric pilonidal sinus disease (PSD) is limited. We aimed to compare the effectiveness of Sinus Laser-Assisted Closure (SiLaC) and Pediatric Endoscopic Pilonidal Sinus Treatment (PEPSiT), with particular emphasis on wound healing and disease recurrence. Methods A retrospective single-center cohort study was conducted including patients younger then 18 years of age treated for PSD between January 2022 and December 2025. The primary outcome was wound healing time. Secondary outcomes included recurrence rate and operative time. Results Seventy-three patients were included: 21 underwent SiLaC and 52 underwent PEPSiT. Baseline demographic characteristics were comparable between groups. Median wound healing time was significantly shorter following SiLaC than PEPSiT (15 [IQR 15–22] vs. 55.5 [IQR 24.3–113.3] days; p < 0.001). Recurrence rates did not differ significantly (14.3% vs. 23.1%; p = 0.492), nor did median operative time (18 vs. 22 minutes; p = 0.089). Follow-up was shorter in the SiLaC group (2 vs. 5 months; p = 0.026). Conclusions SiLaC was associated with significantly faster wound healing and similar short-term recurrence rates. Its compatibility with lateral positioning and with local or locoregional anaesthesia may further enhance postoperative recovery. Prospective studies with longer follow-up are warranted to confirm long-term efficacy and cost-effectiveness.
Authors
- Filippo Ghidini (ORCID: https://orcid.org/0000-0003-1050-642X)
- Ciro Andolfi (ORCID: https://orcid.org/0000-0002-1844-377X)
- Sandy Jochault‐Ritz
- Claire Bontems
Institutions
- Université Libre de Bruxelles (BE)
- Hopitaux Civils de Colmar (FR)
Publication Details
- Journal
- Pediatric Surgery International
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1007/s00383-026-06728-5
- Primary Topic
- Anorectal Disease Treatments and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00